Epilepsy has affected over 50 million people worldwide, and is one of the world’s most common neurological conditions. It could be fatal if detected late and left untreated.
Against this background, a Bengaluru-based startup has come up with an innovative solution for the detection and treatment of epilepsy. Terra Blue is a young, socially responsible organisation focused on leveraging technological innovations to bring positive changes to the lives of people with chronic health disorders.
“Empathy is one of our core values. We combine this with our focus on innovative technology, enabling us to more effectively understand what our target users, be it doctors, caregivers, patients or general consumers, really want”, says Rajlakshmi Borthakur, Founder & CEO, Terra Blue.
Incubated at the Bangalore Bioinnovation Centre, Terra Blue has worked towards creating a holistic Internet of Things (IoT) ecosystem, combining proprietary hardware and software for coming up with innovative solutions to understand and manage chronic and neurological disorders.
The company’s flagship product is a wearable device called TJay, a patent-pending IoT solution for the holistic management of epilepsy. It is a two-part solution, consisting of a glove with embedded biomedical sensors and a Machine Learning (ML) / Artificial Intelligence (AI)-based mobile app that runs in the cloud, syncing with the wearable device to provide real-time alerts before the onset of an epileptic seizure. What’s unique about this solution is its versatility, combined with its primary purpose of predicting the onset of epilepsy. It records information from the body and passes it on to the mobile app. The data, stored on the cloud, can prove immensely valuable for understanding patterns behind seizures, along with helping gauge the severity of an attack to assess if it is life-threatening.
Xaant is Terrablue’s patent-pending wearable device that can be worn as a strap or as smart jewellery.
TJay is a patent-pending IoT solution for the holistic management of epilepsy.
What’s unique about this solution [TJay] is its versatility, combined with its primary purpose of predicting the onset of epilepsy.
The company had its genesis in 2015, when Rajlakshmi Borthakur, mother to a young boy named Tejas, contended with the problem of how she could receive preemptive indication of her son’s epileptic seizures. Starting with a simple attempt to create a prototype for the early detection of epilepsy, through the use of biomedical sensors and means to alert caregivers of an impending seizure, Terra Blue was born in 2016.
In the future, the firm intends to get into other areas of healthcare technology as well, such as cardiac care, provision of continued support to caregivers and even implantable devices. The company posits that combining AI with robotics is likely to be a key step in furthering the healthcare revolution.